Insider Title Company Date Price Return Shares Value
Vivo Capital Viii, Llc Non-Executive IMPEL NEUROPHARMA INC (IMPL) 2021-04-27 $15.00 -99.9% 575,000 $8,625,000
Vivo Capital Viii, Llc Non-Executive Terns Pharmaceuticals, Inc. (TERN) 2021-02-09 $17.00 -56.1% 475,000 $8,075,000
Vivo Capital Viii, Llc Non-Executive Bolt Biotherapeutics, Inc. (BOLT) 2021-02-09 $400.00 -99.8% 17,500 $7,000,000
Vivo Capital Viii, Llc Non-Executive Aligos Therapeutics, Inc. (ALGS) 2020-10-20 $375.00 -96.8% 22,000 $8,250,000
Return Profit / (loss) Cost
Total -88.0% $-28,123,441 $31,950,000